Taysha Gene Therapies Shares Halted To The Downside, Stock Currently Down -21.09%
Portfolio Pulse from Benzinga Newsdesk
Taysha Gene Therapies shares have been halted to the downside, with the stock currently down by 21.09%.
June 18, 2024 | 1:36 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Taysha Gene Therapies shares have been halted to the downside, with the stock currently down by 21.09%. This significant drop indicates potential issues or negative news affecting the company.
The halt and significant drop in Taysha Gene Therapies' stock price suggest that there may be underlying issues or negative news impacting the company. Investors should be cautious and look for further information.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100